Published in EJC Suppl on September 01, 2013
Racial differences in six major subtypes of melanoma: descriptive epidemiology. BMC Cancer (2016) 0.75
Metastatic pathway and the microvascular and physicochemical microenvironments of human melanoma xenografts. J Transl Med (2017) 0.75
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol (2009) 23.08
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (1992) 18.26
Distinct sets of genetic alterations in melanoma. N Engl J Med (2005) 17.26
A cell cycle regulator potentially involved in genesis of many tumor types. Science (1994) 13.00
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature (2008) 8.42
Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst (1999) 8.15
Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol (2006) 7.76
Mutations in GNA11 in uveal melanoma. N Engl J Med (2010) 7.52
Frequent mutation of BAP1 in metastasizing uveal melanomas. Science (2010) 7.47
Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma. J Clin Oncol (2011) 7.18
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (1994) 6.06
Regulation of Raf-1 by direct feedback phosphorylation. Mol Cell (2005) 5.88
Germline p16 mutations in familial melanoma. Nat Genet (1994) 5.59
G protein pathways. Science (2002) 5.29
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 5.09
BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene (1998) 4.88
The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med (1999) 4.38
Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev (2006) 4.24
A review of human carcinogens--part D: radiation. Lancet Oncol (2009) 4.22
Active Ras induces heterodimerization of cRaf and BRaf. Cancer Res (2001) 4.20
Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med (1995) 4.10
Indoor tanning and risk of melanoma: a case-control study in a highly exposed population. Cancer Epidemiol Biomarkers Prev (2010) 3.95
Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet (2011) 3.91
Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet (2009) 3.89
Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res (2004) 3.83
Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat Genet (2008) 3.79
Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst (2003) 3.65
Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst (1993) 3.52
Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology (2011) 3.52
The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review. Int J Cancer (2007) 3.50
Melanocyte biology and skin pigmentation. Nature (2007) 3.43
Prognostic implications of monosomy 3 in uveal melanoma. Lancet (1996) 3.26
Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci (2008) 3.14
Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors. Cancer Res (2005) 2.98
Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev (2008) 2.94
Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science (1992) 2.89
NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression. Clin Cancer Res (2003) 2.72
Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst (2003) 2.70
Melanoma and sun exposure: an overview of published studies. Int J Cancer (1997) 2.65
The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol (1994) 2.64
Clinicopathological features of and risk factors for multiple primary melanomas. JAMA (2005) 2.62
Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci (2003) 2.58
KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res (2008) 2.57
Sun exposure predicts risk of ocular melanoma in Australia. Int J Cancer (2002) 2.50
In utero manipulation of coat color formation by a monoclonal anti-c-kit antibody: two distinct waves of c-kit-dependency during melanocyte development. EMBO J (1991) 2.48
Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res (1998) 2.44
The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. J Biol Chem (2009) 2.40
Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst (1984) 2.39
Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N Engl J Med (1995) 2.34
Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst (2004) 2.32
Genetics of hair and skin color. Annu Rev Genet (2003) 2.31
Incidence of uveal melanoma in Europe. Ophthalmology (2007) 2.30
Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol (2010) 2.30
Ultraviolet A and melanoma: a review. J Am Acad Dermatol (2001) 2.27
Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes. J Invest Dermatol (2006) 2.25
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet (2006) 2.17
Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients. Cancer (1997) 2.15
Vascular involvement in the prognosis of primary cutaneous melanoma. Arch Dermatol (2001) 2.12
Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer (2005) 2.09
Increased cancer mortality following a history of nonmelanoma skin cancer. JAMA (1998) 2.02
Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials. J Clin Oncol (2012) 1.93
Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer (2000) 1.90
MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A. J Cell Biol (2004) 1.89
BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Res (2006) 1.85
Incidence of noncutaneous melanomas in the U.S. Cancer (2005) 1.85
Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol (2012) 1.83
Oral mucosal melanoma: epidemiology and pathobiology. Oral Oncol (2000) 1.83
Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. Proc Natl Acad Sci U S A (1991) 1.81
Primary mucosal melanoma. J Am Acad Dermatol (2007) 1.80
Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol (2011) 1.78
Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma. Int J Cancer (2011) 1.76
Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One (2012) 1.76
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med (2012) 1.76
BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity. Cancer Res (2009) 1.72
Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia. J Clin Oncol (2012) 1.68
MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet (2001) 1.67
Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res (2000) 1.67
The prognostic significance of ulceration of cutaneous melanoma. Cancer (1980) 1.66
What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65
Soluble and cell-bound forms of steel factor activity play distinct roles in melanocyte precursor dispersal and survival on the lateral neural crest migration pathway. Development (1995) 1.64
Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med (1985) 1.64
Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol (1990) 1.62
A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group. Ann Intern Med (1996) 1.62
Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA (1998) 1.62
Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci U S A (1992) 1.58
Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. Cancer Epidemiol Biomarkers Prev (2010) 1.56
Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer (1998) 1.56
Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner. Clin Cancer Res (2012) 1.52
The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer Epidemiol Biomarkers Prev (2006) 1.51
Primary malignant melanoma of the oral cavity in Japan. With special reference to mucosal melanosis. Cancer (1974) 1.50
Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window. Br J Ophthalmol (2002) 1.49
Large-scale analysis of KIT aberrations in Chinese patients with melanoma. Clin Cancer Res (2011) 1.47
Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes Control (2007) 1.44
Age as a prognostic factor in the malignant melanoma population. Ann Surg Oncol (1994) 1.43